Women experiencing menopause now have a new weapon against some of its toughest symptoms: fezolinetant, an FDA-approved non-hormonal medication that's delivering real relief in the real world. A groundbreaking study presented at the Endocrine Society's annual meeting found the treatment significantly improved hot flashes, depression, and anxiety—without requiring hormone replacement therapy.

This marks a major shift in menopause care, offering an alternative for women who can't or prefer not to use traditional hormone treatments. The research gives fresh evidence that addressing menopause symptoms goes beyond managing discomfort; it's about reclaiming quality of life during a major life transition that affects roughly one in eight women worldwide. Read the full story →

Today's takeaway: Medical innovation continues to expand treatment options, proving that menopause symptoms deserve—and are finally getting—serious scientific attention.